Literature DB >> 15528066

Intensity-modulated radiation therapy reduces the dose to normal tissue in T2N0M0 squamous cell carcinoma of the glottic larynx.

José A Peñagarícano1, Vaneerat Ratanatharathorn, Niko Papanikolaou, Yulong Yan.   

Abstract

The purpose of this paper was to compare intensity-modulated radiation therapy (IMRT) and conventional planning for T2N0M0 squamous cell carcinoma (SQCC) of the glottic larynx. Three patients with T2N0M0 SQCC are presented who were treated with IMRT. Conventional plans were also generated for comparison purposes. Isodose distributions and dose-volume histograms (DVHs) were generated for all the plans to evaluate the fitness of the plan as well as the differential benefit of IMRT vs. conventional treatment. The isodose distributions that were obtained by the IMRT plan are much more conformal to the planning target volume (PTV) and clearly show that less healthy tissue is subjected to a high-dose level, thus reducing toxicity. IMRT offers better comformality without compromising the PTV coverage and delivers less dose to normal tissues as compared to conventional radiation therapy in T2N0M0 SQCC of the glottic larynx. With an increase in conformality, it is expected to have an increase in the therapeutic ratio.

Entities:  

Mesh:

Year:  2004        PMID: 15528066     DOI: 10.1016/j.meddos.2003.12.002

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  4 in total

1.  Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.

Authors:  David I Rosenthal; Clifton D Fuller; Jerry L Barker; Bryan Mason; John A Garcia; Jan S Lewin; F Christopher Holsinger; C Richard Stasney; Steven J Frank; David L Schwartz; William H Morrison; Adam S Garden; K Kian Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-11       Impact factor: 7.038

2.  Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.

Authors:  Stefan Janssen; Christoph Glanzmann; Gerhard Huber; Gabriela Studer
Journal:  Radiat Oncol       Date:  2014-06-13       Impact factor: 3.481

3.  Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer.

Authors:  Jun Won Kim; Hyung Kwon Byeon; Hong-Shik Choi; Ik Jae Lee
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

Review 4.  Feasibility of intensity-modulated and image-guided radiotherapy for functional organ preservation in locally advanced laryngeal cancer.

Authors:  Nam P Nguyen; Alexander Chi; Michael Betz; Fabio Almeida; Paul Vos; Rick Davis; Benjamin Slane; Misty Ceizyk; Dave Abraham; Lexie Smith-Raymond; Michelle Stevie; Siyoung Jang; Steven Gelumbauskas; Vincent Vinh-Hung
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.